-+ 0.00%
-+ 0.00%
-+ 0.00%

Everest Medicines appoints Yue Wang as non-executive director

PUBT·08/14/2026 09:05:11
Listen to the news
Everest Medicines appoints Yue Wang as non-executive director
  • Everest Medicines named Yue Wang as a non-executive director, effective Aug. 14, 2026.
  • William Ki Chul Cho resigned as a non-executive director, effective Aug. 14, 2026.
  • Wang is an operating partner at CBC Group, a substantial shareholder.
  • She previously led investor relations at Duality Biotherapeutics, served as its IR and PR vice president.
  • Wang was vice president of investor relations at WuXi Biologics from 2017 to 2024.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260814-12284552), on August 14, 2026, and is solely responsible for the information contained therein.